Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

The growing prevalence of diabetes across the globe is driving demand for diabetes medications. Contributing factors such as sedentary lifestyles, increasing obesity rates, and an aging population are ...